About: http://data.cimple.eu/news-article/16f3e57953814e4c175410d2601967787f210e68f97ec06e6b148307

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/16f3e57953814e4c175410d2601967787f210e68f97ec06e6b148307 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Nearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm said, although it has not yet provided any clear clinical evidence of efficacy. China has been giving experimental Covid-19 vaccines to people including state employees, international students and essential workers heading abroad since July. Sinopharm's chairman told media this week that nearly a million people have now received their vaccine for emergency use, though he did not provide a specific figure. "We have not received a single report of severe adverse reaction, and only a few had some mild symptoms," Liu Jingzhen said in an interview re-published by the state-owned firm on Wednesday. China has been bullish about the development of its vaccine for the new virus -- which first emerged in the centre of the country late last year -- with four vaccines now in late-stage testing. Many of the trials are taking place overseas, as China has largely brought the virus under control within its borders. Sinopharm is testing two vaccines in late-stage trials in countries including the UAE, Bahrain, Egypt, Jordan, Peru and Argentina. The company claimed this week to be "leading the world in all aspects" of vaccine development, although it did not offer clinical evidence from ongoing trials. Instead it cited anecdotal experiences from those who have been inoculated, including "construction personnel, diplomats, and overseas students" who it said have gone on to visit more than 150 countries after vaccination without being infected. President Xi Jinping has declared that any Chinese vaccine would be a "global public good", after the country came under criticism, particularly from the US, for its early handling of the outbreak. Many who have been inoculated in China are not formal participants in drugmakers' trials and are said to have done so voluntarily. Competition has intensified among pharmaceutical companies racing to develop a Covid-19 shot, with two vaccines -- one by US company Pfizer and its German partner BioNTech, and another by US firm Moderna -- publishing large-scale trial data this month that showed their jabs were around 95 percent effective against Covid-19. bys/rox/oho
schema:headline	Almost a million people inoculated with Chinese Covid-19 vaccine: firm
schema:mentions	Jordan Bahrain Pharmaceutical industry Ebola virus disease Egypt United Arab Emirates Xi Jinping President of Russia Peru Argentina Pfizer Vaccine China Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Global public good China National Pharmaceutical Group
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-11-20 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	87 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software